StockFin.ai
NewsScreensInsightsPricing
/
Sign inTry Free
SF
New ChatNewsInsightsScreenerPricing
Sign In
NewsScreensChatSign In

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing

ERIS Lifesciences Ltd

₹1,236▼ -1.96%28 Sept
📡AI Radar📊 Stock Analysis
OverviewNews✨ChartPeersQuartersProfit & LossBalance SheetCash FlowInvestors
Market Data
Market Cap₹17,128.3 Cr.
52W High₹1,737
Current Price₹1,236
52W Low₹1,231.25
Down from 52W High28.8 %
Face Value₹1
Performance
ROCE13.64 %
ROE16.5 %
EPS (TTM)₹10.28
EPS Prev Qtr₹20.6
EPS Last Year₹8.82
EBITDA Qtr₹224.15 Cr.
Book Value₹282
Financial Health
Debt/Equity0.59
Debt/Profit3.47
Total Assets₹7,365.51 Cr.
Dividend Yield0.58 %
Promoter Holding54.14 %
Earning Power11.66 %
Valuation
Stock P/E26.29
Industry P/E33.81
Price to Book4.39
Price to Sales5.3
Graham Number₹545.77

Key Metrics

Debt/Equity
0.64
Face Value
₹1
Interest Coverage
4.86

About ERIS Lifesciences Ltd

Healthcare · Pharmaceuticals

ERIS Lifesciences Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹1. Market cap ₹17,128.3 Cr.

Price Chart
₹1,213₹1,341₹1,469₹1,597₹1,7252025-09-292025-12-102026-02-192026-05-082026-07-202026-09-28

Peer Comparison

NameCMPP/EMarket CapDiv YieldNP QtrQtr Profit Var%Sales QtrQtr Sales Var%ROCE%Debt/Eq
Sun Pharmaceutical Industries Ltd-36.51₹4,41,477.63 Cr0.87%₹12,172.7 Cr-₹59,910.52 Cr-18.72%0.05
Divis Laboratories Ltd-86.48₹2,53,031.38 Cr0.31%₹2,925 Cr-₹11,230 Cr-23.04%0
Torrent Pharmaceuticals Ltd-77.67₹1,85,216.32 Cr0.78%₹2,156 Cr-₹15,723 Cr-15.1%1.76
Zydus Lifesciences Ltd-27.01₹1,20,897.46 Cr0.08%₹4,492.2 Cr-₹28,591.7 Cr-16.76%0.43
Cipla Ltd-33.28₹1,12,201.64 Cr0.94%₹3,364.84 Cr-₹28,324.4 Cr-13.24%0.01
Laurus Labs Ltd-99.31₹1,08,698.22 Cr0.06%₹1,090.76 Cr-₹7,269.64 Cr-20.79%0.45
Dr Reddys Laboratories Ltd-31.6₹1,02,039.12 Cr0.65%₹3,183.3 Cr-₹33,227.9 Cr-10.05%0.17
Mankind Pharma Ltd-49.29₹1,00,752.43 Cr0.04%₹2,067.57 Cr-₹14,737.88 Cr-13.95%0.38
Aurobindo Pharma Ltd-26.56₹97,814.24 Cr0.24%₹3,710.8 Cr-₹34,935.29 Cr-12.75%0.2
Lupin Ltd-16.64₹94,274.49 Cr0.87%₹5,550.99 Cr-₹29,966.58 Cr-27.95%0.26
Glenmark Pharmaceuticals Ltd-36.67₹65,922.11 Cr0.11%₹1,797.81 Cr-₹17,736.56 Cr-24.78%0.25
Alkem Laboratories Ltd-28.65₹61,804.34 Cr1.03%₹2,206.3 Cr-₹15,081.28 Cr-19.75%0.12
Biocon Ltd-110.29₹61,113.53 Cr0.13%₹416.4 Cr-₹17,321.1 Cr-2.87%0.43
Abbott India Ltd-35.22₹56,860.69 Cr1.78%₹1,614.68 Cr-₹7,004.38 Cr-45.73%0
Glaxosmithkline Pharmaceuticals Ltd-46.73₹49,091.33 Cr1.97%₹1,068.15 Cr-₹3,954.94 Cr-64.07%0
Ipca Laboratories Ltd-36.13₹48,712.48 Cr0.31%₹1,379.76 Cr-₹10,125.58 Cr-21.48%0.09
Anthem Biosciences Ltd-83.03₹47,949.68 Cr0.23%₹575.95 Cr-₹2,002.34 Cr-25.5%0.02
Gland Pharma Ltd-42.26₹47,764.08 Cr0.69%₹1,128.8 Cr-₹6,725.3 Cr-15.21%0.02
Ajanta Pharma Ltd-38.87₹44,109.77 Cr0.79%₹1,134.88 Cr-₹5,776.17 Cr-31.81%0.05
J B Chemicals & Pharmaceuticals Ltd-53.3₹38,730.77 Cr0.39%₹709.46 Cr-₹4,147.79 Cr-23.03%0

Quarterly Results

Sep 2025Dec 2025Mar 2026Jun 2026
Sales792.41807.45756.56873.25
↳ QoQ Growth-+1.9%-6.3%+15.4%
Expenses573.28596.18552.56649.1
Operating Profit219.13211.27204224.15
OPM %27.65%26.17%26.96%25.67%
Other Income2.810.022.232.39
Interest49.5548.8245.6246.65
Depreciation69.0870.3469.5772.07
EBITDA288.21281.61273.57296.22
EBITDA Margin %36.37%34.88%36.16%33.92%
Profit Before Tax172.67145.35159.41179.49
Tax %22.12%25.13%-75.08%20.15%
Net Profit134.47108.83279.1143.32
↳ QoQ Growth--19.1%+156.5%-48.6%
EPS8.827.3220.610.28

Balance Sheet

Mar 2025Mar 2026
Equity Capital13.6213.85
Reserves2840.743888.82
Borrowings2477.922309.68
Other Liabilities1704.131153.16
Total Liabilities7036.417365.51
Fixed Assets662.075187.56
CWIP66.74171.47
Investments6761.56
Other Assets6240.61944.92
Total Assets7036.417365.51

Cash Flows

Mar 2025Mar 2026
Cash from Operating Activity1065.01537.99
Cash from Investing Activity-79.97-369.46
Cash from Financing Activity-881.32-313.53
Net Cash Flow103.72-145

Shareholding Pattern

Sep 2025Dec 2025Mar 2026Jun 2026
Promoters %54.85%54.85%53.92%54.14%
FIIs %7.21%6.85%6.39%5.75%
DIIs %19.36%20.32%20.35%20.72%
Public %9.12%8.51%10.06%10.1%
No. of Shareholders59,43854,71351,65650,798

Major Shareholders (>1%)

  • Amit Indubhusan BakshiPromoter and Promoter Group42.34%
  • Lilac Investments LimitedPublic Shareholding8.63%
  • Hdfc Small Cap FundPublic Shareholding8.33%
  • Inderjeet Singh NegiPromoter and Promoter Group4.29%
As of 2026-06-30View all shareholders →

Documents

Concall Transcripts

Q1 FY27PDF
View all transcripts →

Investor Presentations

Q1 FY27PDF
Q4 FY26PDF
View all presentations →

© 2026 StockFin.ai is not a SEBI-registered advisor. For informational purposes only.

Data provided by CMOTS Internet Technologies Pvt Ltd

AboutPrivacy PolicyTerms of ServicePricing

Insights & Analysis

View all →

Hitachi Energy India Ltd (POWERINDIA) — Q1FY27 Results

28 SeptPOWERINDIA
Read more →

IEX (BESS) — Future Outlook

28 SeptBESS
Read more →

Financials Recovery Trend — Nifty 50 Weekly Decline 0.88%

28 Sept
Read more →
📊 Analysis

Sugal & Damani Share Brokers Ltd — Financial Results Analysis

28 Sept511654
Read more →
📊 Analysis

KKalpana Industries (India) Ltd — Financial Results Analysis

28 Sept526409
Read more →
📊 Analysis

Krsnaa Diagnostics Ltd — Financial Results Analysis

28 SeptKRSNAA
Read more →
📊 Analysis

Prasol Chemicals Ltd — Financial Results Analysis

28 SeptPRASOLCHEM
Read more →
📊 Analysis

Rays of Belief Ltd — Financial Results Analysis

28 SeptMOMSBELIEF
Read more →
📊 Analysis

Globe Commercials Ltd — Financial Results Analysis

28 Sept540266
Read more →
📊 Analysis

Deepa Jewellers Ltd — Financial Results Analysis

28 SeptDEEPA
Read more →